UNSPSC 51343822: Atazanavir/ritonavir

Definition: This classification denotes a combination drug for treatment of HIV. The first component, ATAZANAVIR is a protease inhibitor with a US FDA Unique Ingredient Identifier of QZU4H47A3S. ATAZANAVIR is an International Non-Proprietary Name or INN. The second component, RITONAVIR, is a pharmacokinetic booster with a US FDA Unique Ingredient Identifier of O3J8G9O825. RITONAVIR is an International Non-Proprietary Name or INN.

UNSPSC 51343822 Atazanavir/ritonavir is a Commodity code that does not accurately reflect the state and local procurement activity tagged to it. The recent opportunities block contains no solicitations for this antiretroviral medication or any pharmaceutical products matching its scope. Instead, the tagged records span unrelated procurement categories: a mobile emergency medical services application (Collier County), pharmaceutical services for long-term care (Dane County), a procurement conference (Clay County), aquatic center operations (Palm Bay), pharmacy network membership (District of Columbia), a naloxone distribution center (Washington County, Oregon), on-call technical services (Owensboro, Kentucky), group purchasing organization membership (San Mateo County), EMS pharmaceuticals and vending systems (Tucson), mental health pharmacy services (West Texas Centers), a purchasing department relocation notice, naloxone and drug deactivation systems (Seminole County), a vendor networking event (Marion County), opioid settlement grants (Bernalillo County), and forensic drug standards (Pinellas County). The code shows no relevant recent activity and appears to be a data-entry or classification error rather than a live procurement category in state and local government purchasing.

No state or local procurement opportunities matching UNSPSC 51343822 or its intended scope appear in the recent activity record. The code is not recommended for active pursuit at this time.